Dr Lalchandani Labs Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002986,
    "name": "Dr Lalchand. Lab",
    "stock_name": "Dr Lalchand. Lab",
    "full_name": "Dr Lalchandani Labs Ltd",
    "name_url": "stocks-analysis/dr-lalchand-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16.71",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "16.71",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541299,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE871Z01013",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": 100000,
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/dr-lalchand-lab-1002986-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Dr Lalchand. Lab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-dr-lalchand-lab-3703832",
        "imagepath": "",
        "date": "2025-11-15 00:15:07",
        "description": "Answer:\nThe historical performance of Dr Lalchand. Lab shows a declining trend in net sales and profitability over the past few years, with a significant drop in total operating income from 11.28 Cr in Mar'22 to 4.45 Cr in Mar'25. The operating profit margin has fluctuated, peaking at 28.9% in Mar'24 before falling to 23.37% in Mar'25. Profit before tax also saw a decline, moving from 1.25 Cr in Mar'22 to 0.40 Cr in Mar'25, while profit after tax decreased from 0.93 Cr in Mar'22 to 0.42 Cr in Mar'25. The company’s total assets decreased from 18.12 Cr in Mar'22 to 15.75 Cr in Mar'25, and total liabilities also saw a reduction from 18.12 Cr to 15.75 Cr in the same period. Cash flow from operating activities has been stagnant, with no inflow reported in the last two years, although there was a net cash inflow of 1.00 Cr in Mar'25.\n\nBreakdown:\nDr Lalchand. Lab's financial performance has shown a notable decline..."
      },
      {
        "title": "When is the next results date for Dr Lalchand. Lab?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-dr-lalchand-lab-3691192",
        "imagepath": "",
        "date": "2025-11-11 23:19:45",
        "description": "Dr Lalchand. Lab is scheduled to declare its results on 14 November 2025...."
      },
      {
        "title": "Why is Dr Lalchand. Lab falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-dr-lalchand-lab-fallingrising-3687285",
        "imagepath": "",
        "date": "2025-11-10 23:27:21",
        "description": "As of 10-Nov, Dr Lalchandani Labs Ltd is experiencing a decline in its stock price, currently at Rs 20.23, which reflects a decrease of Rs 1.06 or 4.98%. The stock has underperformed its sector by 3.4% today and opened with a loss of 4.98%. It has shown erratic trading patterns, not trading on 3 out of the last 20 days, and has touched an intraday low of Rs 20.23. Additionally, the delivery volume has decreased by 23.08% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 9.73%, while it has shown a year-to-date increase of 19.70%.\n\nIn the broader market context, the Sensex has only decreased by 0.53% over the past week, suggesting that the stock's decline is more pronounced than the overall market trend. While the stock has performed well year-to-date and over the past year, with increases of 19.70% and 12.39% respectively, its long-term p..."
      }
    ],
    "total": 54,
    "sid": "1002986",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/dr-lalchandani-labs-1002986"
  },
  "announcements": [
    {
      "caption": "Newspaper Publication Under Regulation 84(1) Of SEBI (ICDR) Regulations",
      "datetime": "31-Jan-2026",
      "details": "Newspaper publication as per stated regulation",
      "source": "BSE"
    },
    {
      "caption": "Letter Of Offer For Rights Issue Of Equity Shares",
      "datetime": "21-Jan-2026",
      "details": "Please find enclosed the soft copy of Letter of Offer dated January 20 2026 for the Rights Issue of Dr Lalchandani Labs Limited. The Company is also submitting this Letter of Offer with Securities and Exchange Board of India (SEBI) for its information in compliance with SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 as amended and SEBI Circular bearing no. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2025/31 dated March 11 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Raising of Funds",
      "datetime": "20-Jan-2026",
      "details": "In continuation of our earlier intimation dated December 16 2025 and subsequent deferment notice dated December 22 2025 we wish to inform you that the meeting of the Board of Directors of Dr Lalchandani Labs Limited (the Company) was duly held today i.e. Tuesday January 20 2025 to consider and approve matters relating to the proposed Rights Issue of Equity Shares of the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Dr Lalchand. Lab?

2025-11-15 00:15:07

Answer: The historical performance of Dr Lalchand. Lab shows a declining trend in net sales and profitability over the past few years, with a significant drop in total operating income from 11.28 Cr in Mar'22 to 4.45 Cr in Mar'25. The operating profit margin has fluctuated, peaking at 28.9% in Mar'24 before falling to 23.37% in Mar'25. Profit before tax also saw a decline, moving from 1.25 Cr in Mar'22 to 0.40 Cr in Mar'25, while profit after tax decreased from 0.93 Cr in Mar'22 to 0.42 Cr in Mar'25. The company’s total assets decreased from 18.12 Cr in Mar'22 to 15.75 Cr in Mar'25, and total liabilities also saw a reduction from 18.12 Cr to 15.75 Cr in the same period. Cash flow from operating activities has been stagnant, with no inflow reported in the last two years, although there was a net cash inflow of 1.00 Cr in Mar'25. Breakdown: Dr Lalchand. Lab's financial performance has shown a notable decline...

When is the next results date for Dr Lalchand. Lab?

2025-11-11 23:19:45

Dr Lalchand. Lab is scheduled to declare its results on 14 November 2025....

Why is Dr Lalchand. Lab falling/rising?

2025-11-10 23:27:21

As of 10-Nov, Dr Lalchandani Labs Ltd is experiencing a decline in its stock price, currently at Rs 20.23, which reflects a decrease of Rs 1.06 or 4.98%. The stock has underperformed its sector by 3.4% today and opened with a loss of 4.98%. It has shown erratic trading patterns, not trading on 3 out of the last 20 days, and has touched an intraday low of Rs 20.23. Additionally, the delivery volume has decreased by 23.08% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has declined by 9.73%, while it has shown a year-to-date increase of 19.70%. In the broader market context, the Sensex has only decreased by 0.53% over the past week, suggesting that the stock's decline is more pronounced than the overall market trend. While the stock has performed well year-to-date and over the past year, with increases of 19.70% and 12.39% respectively, its long-term p...

View All News